Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 12 April 2011
Vol. 4, Issue 168, p. ra23
[DOI: 10.1126/scisignal.2001617]
RESEARCH ARTICLES
Editor's Summary
The Integrating Isoform
The class I phosphoinositide 3-kinases (PI3Ks) are implicated in processes such as growth factor signaling and inflammation. PI3K is activated by G protein–coupled receptors (GPCRs), whereas PI3Kα and PI3K are activated by protein tyrosine kinase–coupled receptors. PI3Kβ is unusual in that it appears to respond to signals from both types of receptors, depending on the cellular context. Kulkarni et al. investigated the responses of mouse neutrophils to immune complexes of antibody and antigen, which trigger chronic inflammation in conditions such as autoimmune arthritis. Genetic and pharmacological evidence suggested that immune complexes stimulated PI3Kβ in a process involving activation of FcR, a tyrosine kinase–coupled low-affinity antibody receptor, and autocrine signaling by a proinflammatory lipid (LTB4) through its GPCR. Mice deficient in PI3Kβ fared better than did controls in models of arthritis and inflammatory skin disease. These data implicate PI3Kβ in the integration of signals from tyrosine kinase–coupled receptors and GPCRs—and suggest that this isoform may be an effective therapeutic target in inflammatory diseases.
Citation: S. Kulkarni, C. Sitaru, Z. Jakus, K. E. Anderson, G. Damoulakis, K. Davidson, M. Hirose, J. Juss, D. Oxley, T. A. M. Chessa, F. Ramadani, H. Guillou, A. Segonds-Pichon, A. Fritsch, G. E. Jarvis, K. Okkenhaug, R. Ludwig, D. Zillikens, A. Mocsai, B. Vanhaesebroeck, L. R. Stephens, P. T. Hawkins, PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes. Sci. Signal.4, ra23 (2011).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
RESEARCH ARTICLES
Hashem A. Dbouk, Oscar Vadas, Aliaksei Shymanets, John E. Burke, Rachel S. Salamon, Bassem D. Khalil, Mathew O. Barrett, Gary L. Waldo, Chinmay Surve, Christine Hsueh, Olga Perisic, Christian Harteneck, Peter R. Shepherd, T. Kendall Harden, Alan V. Smrcka, Ronald Taussig, Anne R. Bresnick, Bernd Nürnberg, Roger L. Williams, and Jonathan M. Backer (4 December 2012) Sci. Signal.5 (253), ra89.
[DOI: 10.1126/scisignal.2003264] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
EDITORS' CHOICE
John F. Foley (10 May 2011) Sci. Signal.4 (172), ec133.
[DOI: 10.1126/scisignal.4172ec133] |Abstract »
RESEARCH ARTICLES
Faruk Ramadani, Daniel J. Bolland, Fabien Garcon, Juliet L. Emery, Bart Vanhaesebroeck, Anne E. Corcoran, and Klaus Okkenhaug (10 August 2010) Sci. Signal.3 (134), ra60.
[DOI: 10.1126/scisignal.2001104] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
Class I Phosphoinositide-3-Kinases and Src Kinases Play a Nonredundant Role in Regulation of Adhesion-Independent and -Dependent Neutrophil Reactive Oxygen Species Generation.
L. Fumagalli, C. C. Campa, G. Germena, C. A. Lowell, E. Hirsch, and G. Berton (2013)
J. Immunol.
190, 3648-3660
|Abstract »|Full Text »|PDF »
Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b {beta}2-integrin-dependent signaling.
S. J. McMillan, R. S. Sharma, E. J. McKenzie, H. E. Richards, J. Zhang, A. Prescott, and P. R. Crocker (2013)
Blood
121, 2084-2094
|Abstract »|Full Text »|PDF »
G Protein-Coupled Receptor-Mediated Activation of p110{beta} by G{beta}{gamma} Is Required for Cellular Transformation and Invasiveness.
H. A. Dbouk, O. Vadas, A. Shymanets, J. E. Burke, R. S. Salamon, B. D. Khalil, M. O. Barrett, G. L. Waldo, C. Surve, C. Hsueh, et al. (2012)
Science Signaling
5, ra89
|Abstract »|Full Text »|PDF »
Insulin Modulates the Inflammatory Granulocyte Response to Streptococci via Phosphatidylinositol 3-Kinase.
S. Kenzel, M. Mergen, J. von Susskind-Schwendi, J. Wennekamp, S. D. Deshmukh, M. Haeffner, A. Triantafyllopoulou, S. Fuchs, S. Farmand, S. Santos-Sierra, et al. (2012)
J. Immunol.
189, 4582-4591
|Abstract »|Full Text »|PDF »
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies.
J. G. Foster, M. D. Blunt, E. Carter, and S. G. Ward (2012)
Pharmacol. Rev.
64, 1027-1054
|Abstract »|Full Text »|PDF »
Emerging anti-inflammatory strategies for COPD.
M. Cazzola, C. P. Page, L. Calzetta, and M. G. Matera (2012)
Eur. Respir. J.
40, 724-741
|Abstract »|Full Text »|PDF »
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases.
O. Vadas, J. E. Burke, X. Zhang, A. Berndt, and R. L. Williams (2011)
Science Signaling
4, re2
|Abstract »|Full Text »|PDF »
is activated by G protein–coupled receptors (GPCRs), whereas PI3Kα and PI3K
are activated by protein tyrosine kinase–coupled receptors. PI3Kβ is unusual in that it appears to respond to signals from both types of receptors, depending on the cellular context. Kulkarni et al. investigated the responses of mouse neutrophils to immune complexes of antibody and antigen, which trigger chronic inflammation in conditions such as autoimmune arthritis. Genetic and pharmacological evidence suggested that immune complexes stimulated PI3Kβ in a process involving activation of Fc
